WebDec 1, 2024 · Rheumatology Network interviewed Philip Mease, MD, to discuss recent Phase 3 data from the DISCOVER-1 and DISCOVER-2 clinical trials, presented at the ACR, which demonstrated guselkumab inhibited radiographic progression, and improved symptoms and pain in patients with active psoriatic arthritis (PsA). Mease is Director of … WebJul 17, 2024 · In the new pooled analysis, Philip Mease, MD, of Swedish Medical Center, Seattle, and colleagues examined the effects of guselkumab in trial participants who had axial symptoms and sacroiliitis before enrollment or at screening. ... The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners ...
Dr. Philip Mease GenQual Corp United States of America
WebFeb 16, 2024 · Dr Philip Mease is a rheumatologist based in Seattle, Washington, USA and has been in practice since 1982. His interest in psoriatic arthritis (PsA) arose after working alongside a dermatology department in Seattle where he treated many patients referred by dermatologists for the treatment of their arthritic component. WebFeb 26, 2024 · In this interview, Helen Fosam, PhD, Medscape Rheumatology, spoke with Philip J. Mease, MD, Chief of Rheumatology Research, Swedish Medical Center, Seattle, Washington, and Clinical Professor of Medicine, University of Washington, Seattle, about the data presented at the American College of Rheumatology (ACR) 2008 Annual Scientific … mag shop pottstown
Philip Mease, MD: The Complexities of Treating Pain in …
WebApr 12, 2024 · The investigational interleukin-17A inhibitor izokibep showed higher response rates across a number of symptoms in adults with psoriatic arthritis (PsA) in an extension of its phase 2 trial out to 46 weeks, according to an announcement reporting some of the long-term data by the drug’s developer, Acelyrin.. Izokibep is an antibody mimetic designed to … WebHear rheumatologists Dr. Philip Mease (Director, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health) and Dr. Ernest Choy (Cardiff University School of Medicine), and patients Melissa Leeolou and Minionette “Mini” Wilson discuss causes, symptoms, risks and the latest in managing chronic pain and fatigue successfully. http://mdedge.ma1.medscape.com/rheumatology/article/262334/psoriatic-arthritis/new-46-week-psa-data-released-il-17a-inhibitor nz army website